The first round of injections are underway in Europe for a trial testing a potential vaccine for COVID-19, the BBC reports.
According to the news agency, the trial is testing an experimental COVID-19 vaccine that was developed by researchers at Oxford University. The study is reportedly being carried out in Oxford and is Europe’s first human trial for a COVID-19 vaccine.
Over 800 people will reportedly participate in the trial, and two people have received injections so far.
As part of the study, half of those recruited will reportedly receive the potential vaccine and the remaining volunteers will be administered a vaccine designed to prevent meningitis.
None of the volunteers will know which of the vaccines they have been administered, the BBC reports.
Sarah Gilbert – who teaches vaccinology at the Jenner Institute, part of the Nuffield Department of Medicine at Oxford University – is reportedly leading the effort.
"Personally I have a high degree of confidence in this vaccine," she told the BBC.
"Of course, we have to test it and get data from humans,” she continued. “We have to demonstrate it actually works and stops people getting infected with coronavirus before using the vaccine in the wider population."
The potential vaccine was reportedly developed from an altered version of a virus that was found in chimpanzees.
Last month, federal officials said that researchers in the U.S. administered the first injection for a trial for a potential COVID-19 vaccine being carried out at the Kaiser Permanente Washington Health Research Institute in Seattle.
The study aims to test the potential vaccine on a group of adults over the course of 6 weeks.